Today: 6 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Meta stock slides as “Meta Compute” plan spotlights AI spending and power risk

Meta stock slides as “Meta Compute” plan spotlights AI spending and power risk

NEW YORK, Jan 13, 2026, 09:36 EST — Regular session Meta Platforms shares slipped 1.7% to roughly $642 in early New York trading Tuesday following CEO Mark Zuckerberg’s announcement of a new “Meta Compute” initiative aimed at expanding the company’s AI infrastructure. The wider market held firm, with the S&P 500 and Nasdaq indices edging up slightly.
Adobe stock slides as Goldman turns bearish; CPI and Firefly AI push set up Tuesday

Adobe stock slides as Goldman turns bearish; CPI and Firefly AI push set up Tuesday

New York, January 12, 2026, 21:18 EST — The market has closed. Adobe slipped 1.9% to $327.65 on Monday, marking its second day of losses, while the broader U.S. market nudged higher. The S&P 500 added 0.16%, the Dow rose 0.17%, with Apple and Alphabet closing up and Microsoft slipping, according to MarketWatch data. Adobe remains about 30% off its 52-week peak, with trading volume slightly below its 50-day average.
Merck stock in focus as MRK lifts $70 billion mid-2030s target and points past Keytruda

Merck stock in focus as MRK lifts $70 billion mid-2030s target and points past Keytruda

New York, Jan 12, 2026, 21:31 EST — The market has closed. Merck & Co boosted its long-term revenue forecast for several new products and pipeline candidates, projecting $70 billion from these “new growth drivers” by the mid-2030s. The company raised its cardiometabolic and respiratory sales outlook to around $20 billion, up from $15 billion, while its infectious-disease forecast jumped to about $15 billion from $5 billion. Merck shares slipped 1.2% to close at $109.19 on Monday. Meanwhile, Johnson & Johnson climbed 2.6%, Eli Lilly added 1.6%, and Pfizer dropped 0.8%.
Synopsys stock rises as CEO flags export curbs, points to March Converge event

Synopsys stock rises as CEO flags export curbs, points to March Converge event

New York, Jan 12, 2026, 21:23 EST — Market closed. Synopsys ended Monday 1.6% higher at $533.42 as investors digested a shareholder letter from CEO Sassine Ghazi. He highlighted “export restrictions” adding “a measure of uncertainty” to 2025 and flagged “execution challenges.” Ghazi also announced the company will showcase its integrated Synopsys-Ansys platform at a “Synopsys Converge” event in Silicon Valley this March.
13 January 2026
KLA stock notches new 52-week high as chip-tool shares firm; Susquehanna lifts target

KLA stock notches new 52-week high as chip-tool shares firm; Susquehanna lifts target

New York, Jan 12, 2026, 21:02 ET — Market closed KLA Corp shares climbed 2.0% Monday, closing at $1,428.17—a fresh 52-week high that topped the previous peak of $1,406.97 from Jan. 6. Trading volume hit 854,084 shares, below the 50-day average, even as the S&P 500 and Dow finished slightly higher. Applied Materials jumped roughly 2.0%, while Lam Research added nearly 1.0%, boosting the iShares Semiconductor ETF by about 0.5%.
AST SpaceMobile stock in focus after AT&T FirstNet sets first-half 2026 satellite target

AST SpaceMobile stock in focus after AT&T FirstNet sets first-half 2026 satellite target

New York, January 12, 2026, 20:10 EST — The market has closed. AST SpaceMobile’s shares closed Monday up 0.7% at $98.39, following news that AT&T’s FirstNet unit plans to roll out satellite coverage for first responders by mid-2026. “You need a layered approach,” said FirstNet President Scott Agnew. Still, Recon Analytics analyst Roger Entner noted AST is “significantly behind” SpaceX’s Starlink project.
Pfizer stock dips as CEO says obesity-drug cash-pay demand looks “almost like Viagra”

Pfizer stock dips as CEO says obesity-drug cash-pay demand looks “almost like Viagra”

New York, January 12, 2026, 20:17 — Market closed. Pfizer Inc. shares fell on Monday after Chief Executive Albert Bourla said the cash-pay market for obesity drugs — where patients pay out of pocket — now works “almost like Viagra”, the erectile-dysfunction drug Pfizer launched in 1998. The company, which bought obesity developer Metsera in a deal valued at up to $10 billion and has said it does not expect to return to revenue growth until 2029, closed down 0.8% at $25.27.
Salesforce (CRM) stock: Goldman starts with a Buy, Barclays lifts target — what to watch before Tuesday

Salesforce (CRM) stock: Goldman starts with a Buy, Barclays lifts target — what to watch before Tuesday

New York, January 12, 2026, 20:14 EST — The market has closed. Salesforce, Inc. shares dipped about 0.2% Monday, even as Goldman Sachs kicked off coverage with a Buy rating and a $330 price target. The stock wrapped at $259.40, after fluctuating between $255.81 and $261.55 during the session. Goldman’s price target implies roughly 27% upside from that close.
13 January 2026
Verizon stock in focus after FCC rewrites phone-unlocking rule tied to fraud losses

Verizon stock in focus after FCC rewrites phone-unlocking rule tied to fraud losses

New York, January 12, 2026, 20:18 ET — Market closed Verizon Communications Inc shares open Tuesday following an update from regulators. The Federal Communications Commission has altered a rule that forced Verizon to unlock phones 60 days after activation. Verizon lobbied for this change, arguing to the agency that the policy was leading to hundreds of millions in annual losses due to fraud.
13 January 2026
1 498 499 500 501 502 879

Stock Market Today

  • Jersey Mike's Targets $12 Billion IPO With Over 3,000 Stores
    July 6, 2026, 1:08 PM EDT. Jersey Mike's has filed for an IPO valuing the sandwich chain at $12 billion. The brand, started in 1956, now runs more than 3,000 U.S. stores and reported $4.3 billion in sales. Jersey Mike's size and recent growth are pushing it further into the fast-casual dining spotlight.
Go toTop